Clover Health Investments (CLOV) Amortization of Deferred Charges (2020 - 2022)

Clover Health Investments has reported Amortization of Deferred Charges for 3 years, with the latest figure at $3000.0 in Q4 2022.

• For the quarter ending Q4 2022, Amortization of Deferred Charges fell 66.67% year-over-year to $3000.0; the trailing twelve-month figure through Dec 2023 stood at $3000.0 (down 90.0% YoY), and the FY2022 full-year result was $30000.0, down 99.78% from the prior year.
• Amortization of Deferred Charges for Q4 2022 stood at $3000.0, down from $9000.0 in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $13.7 million in Q1 2021, with the low at $3000.0 in Q4 2022.
• Historically, Amortization of Deferred Charges has averaged $3.0 million across 3 years, with a median of $26000.0 in 2021.
• The largest YoY upside for Amortization of Deferred Charges was 40076.47% in 2021 against a maximum downside of 99.79% in 2021.
• Clover Health Investments' Amortization of Deferred Charges stood at $2.3 million in 2020, then plunged by 99.62% to $9000.0 in 2021, then slumped by 66.67% to $3000.0 in 2022.
• The last three Amortization of Deferred Charges figures came in at $3000.0 (Q4 2022), $9000.0 (Q3 2022), and $18000.0 (Q2 2022), per Business Quant data.